Helen Keller Hospital Brings State-of-the-Art Imaging to the Shoals GE Healthcare's Discovery PET/CT 710
July 22, 2013Helen Keller Hospital has brought world-class imaging technology to the Shoals with the addition of the GE Healthcare Discovery PET/CT 710. The unit features 64 slice imaging capabilities and is designed to comfortably accommodate larger individuals. The PET/CT 710 combines the anatomical information from the CT and functional information from the PET to create a combined image during one scan. Predominately used as a tool in monitoring cancer, the PET scan allows the clinician to monitor metabolic activity, and the CT scan provides an image of the tumor. The primary advantages of the PET/CT are earlier diagnosis, more accurate tumor location, and precise treatment and monitoring.
In addition, the radiation dosage is approximately 50% lower than traditional CT scans due to many low-dose innovations being incorporated into the Discovery PET/CT 710. These innovations, such as increased sensitivity of the scanner and a dose management solution integrated into the imaging network, minimize the radiation doses required for imaging. Radiation doses using the PET/CT 710 are as much as 50% less than traditional CT scans.
The PET/CT 710 allows clinicians to monitor progress and fine tune treatment plans. The advantage for physicians is the ability to more accurately differentiate between benign and malignant tumors. Due to precise imaging capabilities, surgeons have the ability to determine the exact location to perform an invasive procedure and radiation oncologists can pinpoint radiation fields to the degree that treatment reaches all the cancer cells with minimal damage to surrounding healthy tissue.
"We are thrilled to bring this state-of-the-art diagnosis and treatment tool to the Shoals," said Doug Arnold, Helen Keller Hospital president and CEO. "The capabilities of the PET/CT 710 far surpass any currently in Northwest Alabama and will allow our patients to stay close to home. This is just another step in the continued development of the North Alabama Cancer Institute."